Authors: Piccart, MJ Di Leo, A Beauduin, M Vindevoghel, A Michel, J Focan, C Tagnon, A Ries, F Gobert, P Finet, C Closon-Dejardin, MT Dufrane, JP Kerger, J Liebens, F Beauvois, S Bartholomeus, S Dolci, S Lobelle, JP Paesmans, M Nogaret, JM

Citation: Mj. Piccart et al., Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer, J CL ONCOL, 19(12), 2001, pp. 3103-3110

Authors: Van den Neste, E de Valeriola, D Kerger, J Bleiberg, H Kusenda, Z Brassinne, C Bartholomeus, S Selleslags, J Hennebert, P Wythouck, H Cazenave, I Lefresne-Soulas, F Piccart, M

Citation: E. Van Den Neste et al., A Phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors, CLIN CANC R, 6(1), 2000, pp. 64-71

Authors: Di Leo, A Crown, J Nogaret, JM Duffy, K Bartholomeus, S Dolci, S Rowan, S O'Higgins, N Paesmans, M Larsimont, D Riva, A Piccart, MJ

Citation: A. Di Leo et al., A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer, ANN ONCOL, 11(2), 2000, pp. 169-175